A National, Multicenter, Randomized, Double-blind, Phase III, Crossover Clinical Trial to Assess the Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Latest Information Update: 28 Feb 2024
At a glance
- Drugs DEH 113 (Primary)
- Indications Dysmenorrhoea
- Focus Registrational; Therapeutic Use
- Acronyms LIBERTA
- Sponsors EMS
Most Recent Events
- 27 Feb 2024 New trial record